Details for New Drug Application (NDA): 075401
✉ Email this page to a colleague
The generic ingredient in TAZTIA XT is diltiazem hydrochloride. There are twenty-six drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.
Summary for 075401
Tradename: | TAZTIA XT |
Applicant: | Actavis Labs Fl Inc |
Ingredient: | diltiazem hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 075401
Mechanism of Action | Calcium Channel Antagonists |
Suppliers and Packaging for NDA: 075401
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TAZTIA XT | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 075401 | ANDA | Actavis Pharma, Inc. | 62037-696 | 62037-696-30 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (62037-696-30) |
TAZTIA XT | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 075401 | ANDA | Actavis Pharma, Inc. | 62037-696 | 62037-696-90 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (62037-696-90) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 120MG | ||||
Approval Date: | Apr 10, 2003 | TE: | AB4 | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 180MG | ||||
Approval Date: | Apr 10, 2003 | TE: | AB4 | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 240MG | ||||
Approval Date: | Apr 10, 2003 | TE: | AB4 | RLD: | No |
Complete Access Available with Subscription